Holger Weis
Chairman chez ALAUNOS THERAPEUTICS, INC.
Fortune : 21 914 $ au 31/03/2024
Profil
Holger Weis is the founder and currently holds the position of President & Principal at Weis Advisors, Inc., which was founded in 2018.
He is also currently serving as Chairman at Alaunos Therapeutics, Inc. since 2020 and as an Independent Director at Jupiter Neurosciences, Inc. since 2021.
In his former positions, Mr. Weis served as Chief Financial Officer & Director at Phenotarget Biosciences, Inc. from 2020 to 2021, Senior Manager at Ernst & Young LLP from 1986 to 2000, Chief Financial Officer & Treasurer at GMP Cos., Inc. from 2000 to 2005, President, Chief Operating & Financial Officer at DemeRx, Inc. from 2011 to 2017, Chief Financial Officer, Secretary & VP at NovaVision, Inc. from 2006 to 2010, and Chief Financial Officer at EnSA Holdings LLC from 2010 to 2011.
Mr. Weis obtained his undergraduate degree from the University of Georgia in 1985.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/06/2023 | 12 107 ( 0,08% ) | 21 914 $ | 31/03/2024 |
Postes actifs de Holger Weis
| Sociétés | Poste | Début |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chairman | 22/09/2023 |
| JUPITER NEUROSCIENCES, INC. | Director/Board Member | 08/09/2021 |
Anciens postes connus de Holger Weis
| Sociétés | Poste | Fin |
|---|---|---|
DemeRx, Inc.
 DemeRx, Inc. BiotechnologyHealth Technology DemeRx, Inc. provides biotechnology services. It focuses on drug addiction among patients coping with chronic pain. The company was founded by Deborah C. Mash on March 1, 2010 and is headquartered in Miami, FL. | President | 24/07/2017 |
NovaVision, Inc.
 NovaVision, Inc. Medical/Nursing ServicesHealth Services NovaVision, Inc., headquartered in Boca Raton, Fla., researches, develops and provides scientifically based, innovative medical technologies to restore the vision of patients with neurological visual loss. NovaVision's Vision Restoration Therapy (VRT) devices work by enhancing neuroplasticity - the brain's ability to adapt and form new connections to overcome injury. NovaVision's VRT devices map areas where vision may be improved and then provide neurostimulation to the appropriate region within the brain's vision-processing areas. Once only available at select medical centers, VRT can now be prescribed by any neurologist, neuro-ophthalmologist, ophthalmologist, optometrist, physiatrists and continues to be recommended by leading neurological, eye and rehab centers nationwide. | Director of Finance/CFO | 01/08/2010 |
GMP Cos., Inc.
 GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology GMP Cos., Inc. develops pharmaceuticals, diagnostic products, and medical devices. The firm is also working on treatments for diabetes, glaucoma, and spinal cord injuries. The company was founded in 1999 and is headquartered in Fort Lauderdale, FL | Director of Finance/CFO | 01/01/2005 |
Formation de Holger Weis
| University of Georgia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology DemeRx, Inc. provides biotechnology services. It focuses on drug addiction among patients coping with chronic pain. The company was founded by Deborah C. Mash on March 1, 2010 and is headquartered in Miami, FL. | Health Technology |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services NovaVision, Inc., headquartered in Boca Raton, Fla., researches, develops and provides scientifically based, innovative medical technologies to restore the vision of patients with neurological visual loss. NovaVision's Vision Restoration Therapy (VRT) devices work by enhancing neuroplasticity - the brain's ability to adapt and form new connections to overcome injury. NovaVision's VRT devices map areas where vision may be improved and then provide neurostimulation to the appropriate region within the brain's vision-processing areas. Once only available at select medical centers, VRT can now be prescribed by any neurologist, neuro-ophthalmologist, ophthalmologist, optometrist, physiatrists and continues to be recommended by leading neurological, eye and rehab centers nationwide. | Health Services |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology GMP Cos., Inc. develops pharmaceuticals, diagnostic products, and medical devices. The firm is also working on treatments for diabetes, glaucoma, and spinal cord injuries. The company was founded in 1999 and is headquartered in Fort Lauderdale, FL | Health Technology |
Jupiter Neurosciences, Inc.
 Jupiter Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company. Its therapeutic candidate, JOTROL is applicable to many central nervous system diseases, including Alzheimer’s disease and traumatic brain injury. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in June 2015 and is headquartered in Jupiter, FL. | Health Technology |
